Navigation Links
Endocare and Galil Medical Announce Settlement of Litigation
Date:7/7/2009

IRVINE, Calif. and YOKNEAM, Israel, July 7 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: ENDO) and privately-held Galil Medical Ltd., today announced that they have entered into a settlement agreement stipulating to termination of the previously announced merger agreement between Endocare and Galil Medical pursuant to which Endocare would have acquired Galil Medical, and the settlement of all related litigation in Delaware Chancery Court.

About Endocare

Endocare, Inc.--www.endocare.com-- is an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing technologies for the treatment of prostate cancer and believes that its proprietary technologies have broad applications across a number of markets, including the ablation of tumors in the kidney, lung and liver and palliative intervention (treatment of pain associated with metastases).

About Galil Medical

Galil Medical is a global medical device company that develops, manufactures and markets innovative products utilizing a proprietary cryoablation platform that incorporates powerful freezing technology and revolutionary 17-gauge cryoablation needle design. The company has offices in Yokneam, Israel; Plymouth Meeting, Pennsylvania; and London. Shareholders include Thomas, McNerney & Partners, The Vertical Group, Investor Growth Capital, Elron Electronic Industries Ltd. (Nasdaq: ELRN) and RDC Rafael Development Corporation, Ltd.

    Investor Contact:
    Matt Clawson
    Allen & Caron, Inc.
    (949) 474-4300
    matt@allencaron.com

    Media Contact:
    Len Hall
    Allen & Caron, Inc.
    (949) 474-4300
    len@allencaron.com

    For Additional Information:
    Martin J. Emerson, CEO
    Galil Medical Ltd.
    484-530-3960

    Michael R. Rodriguez, CFO
    Endocare, Inc.
    (949) 450-5400


'/>"/>
SOURCE Endocare, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Endocare Reports Financial Results for Third Quarter 2008
2. Endocare Reports 2008 First Quarter Financial Results
3. Advance Nanotechs Owlstone Subsidiary Receives a $629,000 Order From Selex Galileo
4. Galil Medical Announces the Appointment of Martin J. Emerson as President and Chief Executive Officer
5. Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration
6. Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
7. Inverness Medical Innovations - Concateno plc, Further Announcement Regarding UK Takeover Code Share Dealing Disclosure Requirements.
8. Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer
9. Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech; Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning
10. 2009 Medical Innovation Summit at Cleveland Clinic to Highlight the Latest Developments in Cancer Care
11. Environmental Tectonics Corporations BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... SAN FRANCISCO , February 12, 2016 /PRNewswire/ ... Precision Medicine Efforts by Enabling Scientific Understanding of ... Disorders and Rare Diseases --> ... for genomic diagnostics in South Asia and a leading ... it would contribute $10 million to the GenomeAsia ...
(Date:2/11/2016)... , Germany and ... QGEN ; Frankfurt Prime Standard: QIA) today ... Targeted RNA Panels for gene expression profiling, expanding QIAGEN,s ... (NGS). The panels enable researchers to select from over ... changes and discover interactions between genes, cellular phenotypes and ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals ... a premier sponsor of the 2016 BioProcess International Awards – Recognizing Excellence ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... more than 150 years, continues today to pursue the highest level of accuracy ... analytical instruments: the AR9 Refractometer and the AR5 Refractometer. Accurate, reliable and ...
Breaking Biology Technology:
(Date:2/9/2016)... Inc. (NASDAQ: AWRE ), a leading supplier of biometrics software ... year ended December 31, 2015.  --> ... $6.9 million, an increase of 61% compared to $4.3 million in ... of 2015 was $2.6 million compared to $0.2 million in the ... --> Higher revenue and operating income in the fourth quarter ...
(Date:2/4/2016)... , Feb. 4, 2016 The field ... one of the most popular hubs of the ... and other huge studies of human microbiota, have ... few years, the microbiome space has literally exploded ... research. This report focuses on biomedical aspects ...
(Date:2/3/2016)... , Feb. 3, 2016 ... addition of the "Emotion Detection and ... Learning, and Others), Software Tools (Facial Expression, ... End Users,and Regions - Global forecast to ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced ...
Breaking Biology News(10 mins):